 MARINA DEL REY, Calif., March 16, 2021 PRNewswire -- Armata Pharmaceuticals, Inc. NYSE American: ARMP Armata or the Company, a biotechnology company focused on pathogen-specific bacteriophage therapeutics for antibiotic-resistant and difficult-to-treat bacterial infections, today announced that the Company will participate in the Oppenheimer 31st Annual Healthcare Conference taking place virtually March 16-18, 2021. 